7 Trends Shaping Global Pharmacy in 2026

cheerful client looking at shelves full of drugs — photo credit: google.com

Nov 6, 2026

Around the world, pharmacy is changing fast. Weight-loss drugs have gone generic in big markets, pharmacists are gaining prescribing powers, AI is moving into the dispensary, and pharmacies in rich countries are under real financial strain. Here are the seven global trends worth knowing about, what each means for Nigeria, and links to read more.

1. Weight-loss drugs go mainstream — and generic

GLP-1 medicines such as semaglutide (Ozempic and Wegovy) were the biggest pharmacy story of 2026. In January, Novo Nordisk launched a once-daily Wegovy pill in the US. It works about as well as the weekly injection, costs less to make and doesn’t need a fridge.

The bigger shift came in March, when semaglutide patents expired in India, China, Brazil and other markets. More than 50 Indian brands launched almost overnight, some at around 90% below the old branded price, and Novo Nordisk cut its own prices in India in response. In April, Canada approved Dr Reddy’s generic — the first generic semaglutide in any G7 country.

Why it matters for Nigeria: India supplies more than half of Africa’s generic medicines, so affordable semaglutide could reach African pharmacies much sooner than expected. Pharmacists will need to watch closely for quality and for fake versions.

2. Pharmacists are becoming prescribers

More countries are letting pharmacists diagnose and treat common conditions directly. England is the clearest example. Its Pharmacy First service delivered over 3.3 million consultations between March 2025 and February 2026 — up 43% on the year before — and a £340 million deal has now added a national pharmacist prescribing service, launched in autumn 2026, with five new prescribing-only conditions such as conjunctivitis, oral thrush and skin infections.

Why it matters for Nigeria: it is a strong model for the ACPN’s push to make community pharmacists part of primary care and health insurance.

3. AI and robots move into the dispensary

Robots that pick and dispense medicines, and AI tools that check interactions, write notes and handle insurance paperwork, are spreading fast. A review of five years of real-world use found AI-supported systems cut medication errors by as much as 75%. Adoption is still slow, though: in a Canadian survey, almost half of pharmacists named AI as the most important trend in pharmacy, but only 3% use AI tools most of the time. The common view is that AI will reposition pharmacists toward patient care, not replace them.

4. Money pressure and drug-price reform in the US

US pharmacies are being squeezed from several sides. The three biggest pharmacy benefit managers (the insurance middlemen) each dropped more than 600 drugs from their 2026 coverage lists. The first Medicare-negotiated drug prices took effect in January, and new “most favored nation” pricing deals and pharmaceutical tariffs are reshaping how drugs are priced. Drug shortages are also rising, and thin margins have led to closures such as Rite Aid’s.

5. A renewed fight against antimicrobial resistance

The WHO has drafted an updated Global Action Plan on Antimicrobial Resistance (AMR) for 2026–2036, and the International Pharmaceutical Federation (FIP) says pharmacists are central to using antibiotics wisely. FIP’s 2026 World Congress in Montreal ran under the theme One Health, One Pharmacy, with AMR and medicine supply among its focus areas.

Why it matters for Nigeria: easy over-the-counter access to antibiotics makes stewardship a big opportunity for community pharmacists.

6. Online pharmacy and a growing market

E-pharmacies, telehealth and home delivery are changing how people buy medicines worldwide. Grand View Research values the global pharmacy market at about US$1.4 trillion in 2025 and expects it to reach US$2.6 trillion by 2033. Novo Nordisk’s Wegovy pill launch — sold through pharmacies and telehealth companies from day one — shows how blended these channels have become.

Why it matters for Nigeria: the PCN’s new Electronic Pharmacy Regulations put Nigeria in step with this global shift.

7. A global squeeze on the pharmacy workforce

Staff shortages are not just a Nigerian problem. In Canada, about half of pharmacists say workforce and retention pressures are a major concern, and US health systems describe workforce strain as a growing problem on top of pricing and supply issues. In the UK, the Pharmacists’ Defence Association is calling for at least two pharmacists in pharmacies that offer expanded clinical services. Demand for pharmacists in richer countries is part of what pulls Nigerian pharmacists abroad.

The bottom line

Globally, pharmacy is moving from dispensing toward clinical care, helped by technology and pushed by cost pressure. Cheaper generics, pharmacist prescribing and digital pharmacy all offer lessons for Nigeria — as long as regulation, quality control and the workforce keep pace.